From the Research Center to the Clinic: Biologics and Other Systemic Therapies Part 1
In episode 48 of Derms and Conditions, our host James Q. Del Rosso, DO, sits down with Andrew Blauvelt, MD, MBA, a clinical trials investigator and former President and Owner of the Oregon Medical Research Center. Dr. Blauvelt has conducted almost 200 clinical trials on biologics and JAK inhibitors! In part 1 of this series, the two discuss the best way to learn about these new therapies for psoriasis.
With 11 biologic medications now available for psoriasis, Dr. Blauvelt recommends breaking them down into three categories based on mechanism: the original TNF blockers, the IL-17 blockers, and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.